Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Kidney Int ; 73(5): 595-607, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18094681

RESUMEN

Aristolochic acid contamination in herbal remedies leads to interstitial fibrosis, tubular atrophy, and renal failure in humans. To study the cellular mechanisms contributing to the pathophysiology of this renal disease, we studied Wistar rats treated with aristolochic acid and measured tubular and interstitial cell proliferation, epithelial/mesenchymal cell marker expression, tubular membrane integrity, myofibroblast accumulation, oxidative stress, mitochondrial damage, tubular apoptosis, and fibrosis. Oxidative stress, a loss of cadherin concomitant with vimentin expression, basement membrane denudation with active caspase-3 expression, and mitochondrial injury within tubular cells were evident within 5 days of administration of the toxin. During the chronic phase, interstitial mesenchymal cells accumulated in areas of collagen deposits. Impaired regeneration and apoptosis of proximal tubular cells resulted in tubule atrophy with a near absence of dedifferentiated cell transmembrane migration. We suggest that resident fibroblast activation plays a critical role in the process of renal fibrosis during aristolochic acid toxicity.


Asunto(s)
Apoptosis , Ácidos Aristolóquicos/toxicidad , Enfermedades Renales/inducido químicamente , Túbulos Renales Proximales/efectos de los fármacos , Mutágenos/toxicidad , Animales , Proliferación Celular , Quimiocina CCL2/orina , Colágeno/análisis , Colágeno/metabolismo , Daño del ADN , Reparación del ADN , Receptor con Dominio Discoidina 1 , Epitelio/efectos de los fármacos , Epitelio/patología , Fibrosis , Antígeno Ki-67/análisis , Enfermedades Renales/patología , Túbulos Renales Proximales/química , Túbulos Renales Proximales/patología , Masculino , Mesodermo/patología , Mitocondrias/patología , Estrés Oxidativo , Ratas , Ratas Wistar , Proteínas Tirosina Quinasas Receptoras/análisis
2.
Nephrol Dial Transplant ; 16(1): 147-50, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11209009

RESUMEN

BACKGROUND: Antioxidant enzyme status changes in experimental models of chronic renal disease with glomerulosclerosis. Most of the studies are performed in rats. We now investigate whether a mouse model with more rapid development of glomerulosclerosis is suitable for the study of radical-associated renal disease. METHODS: Female BALB/c mice are injected intravenously with a single dose of adriamycin (10 mg/kg). The development of glomerular and interstitial injury is evaluated by means of renal function parameters and histology. Renal cortex activities of catalase, Cu/Zn and Mn superoxide dismutase and glutathione peroxidase are measured by enzymatic techniques, and their mRNA levels by Northern blot analysis. RESULTS: The mice develop proteinuria and hypercholesterolaemia; glomerulosclerosis is present 20 days after adriamycin injection. Involvement of reactive oxygen intermediates in the disease process is supported by an increased cortex level of glutathione (1.77+/-0.13 vs 1.31+/-0.12 micromol/g kidney; P = 0.021) and ferric iron deposition in the tubulointerstitial compartment. Glomerulosclerosis and tubulointerstitial lesions are accompanied by decreased cortex activities of catalase (0.19+/-0.01 vs 0.23+/-0.01 U/mg protein; P = 0.024), glutathione peroxidase (0.28+/-0.01 vs 0.32+/-0.01 U/mg protein; P = 0.049) and Mn superoxide dismutase (6.61+/-0.91 vs 9.25+/-0.99 U/mg protein, P = 0.020). We find decreased cortex mRNA levels only for glutathione peroxidase. CONCLUSION: The fast development of glomerulosclerosis combined with an altered antioxidant status makes this mouse adriamycin model a suitable alternative for the slower rat models.


Asunto(s)
Antioxidantes/metabolismo , Glomeruloesclerosis Focal y Segmentaria/enzimología , Animales , Catalasa/genética , Catalasa/metabolismo , Modelos Animales de Enfermedad , Doxorrubicina/toxicidad , Femenino , Glomeruloesclerosis Focal y Segmentaria/inducido químicamente , Glomeruloesclerosis Focal y Segmentaria/genética , Glomeruloesclerosis Focal y Segmentaria/patología , Glutatión Peroxidasa/genética , Glutatión Peroxidasa/metabolismo , Corteza Renal/enzimología , Ratones , Ratones Endogámicos BALB C , Estrés Oxidativo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Especies Reactivas de Oxígeno/metabolismo , Especificidad de la Especie , Superóxido Dismutasa/genética , Superóxido Dismutasa/metabolismo , Factores de Tiempo
3.
Nephron ; 86(2): 167-75, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11014987

RESUMEN

Excessive generation of reactive oxygen intermediates can induce changes in the cellular antioxidant defence system. In this study we examine the antioxidant enzyme status and the expression of fibrosis-related marker proteins in the Adriamycin model of chronic renal failure in the rat. Twenty weeks after Adriamycin treatment, rats have overt nephrotic syndrome and renal failure with development of tubulo-interstitial fibrosis and glomerulosclerosis. Lipids accumulate in blood and in both glomeruli and tubulo-interstitial tissue. Desmin and alpha-smooth muscle actin expression increases in glomeruli and in the tubulo-interstitial area. Renal cortex antioxidant enzyme activities are decreased 20 weeks after Adriamycin injection (to 41% for catalase, to 56% for total superoxide dismutase and to 69% for glutathione peroxidase). The mRNA levels of catalase, Cu/Zn-superoxide dismutase and glutathione peroxidase-1 evaluated by Northern blot are decreased by more than 50% for catalase, Cu/Zn-superoxide dismutase and glutathione peroxidase-1. We conclude that in the rat Adriamycin-induced model of chronic renal failure with fibrosis, the combination of decreased antioxidant enzyme status in renal cortex with high concentrations of lipids in blood and renal tissue facilitates oxidative damage. Development of fibrosis is paralleled by increased expression of desmin and alpha-smooth muscle actin.


Asunto(s)
Catalasa/metabolismo , Doxorrubicina/toxicidad , Glutatión Peroxidasa/metabolismo , Riñón/enzimología , Riñón/patología , Superóxido Dismutasa/metabolismo , Animales , Biomarcadores/análisis , Presión Sanguínea/efectos de los fármacos , Catalasa/genética , Desmina/análisis , Desmina/genética , Fibrosis , Glutatión Peroxidasa/genética , Hemodinámica/efectos de los fármacos , Riñón/efectos de los fármacos , Corteza Renal/enzimología , Masculino , Modelos Animales , Síndrome Nefrótico/inducido químicamente , Síndrome Nefrótico/enzimología , Síndrome Nefrótico/patología , Ratas , Ratas Wistar , Valores de Referencia , Insuficiencia Renal/inducido químicamente , Insuficiencia Renal/enzimología , Insuficiencia Renal/patología , Superóxido Dismutasa/genética , Factores de Tiempo , Transcripción Genética
4.
Exp Nephrol ; 8(2): 91-6, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10729748

RESUMEN

Reactive oxygen intermediates play a role in chronic renal injury and glomerulosclerosis. We investigate changes in renal cortex antioxidant enzyme gene expression in the rat remnant-kidney model of chronic renal failure and compare the new data to enzyme activities published earlier. Antioxidant enzyme gene expression is evaluated by Northern blot analysis of cortex mRNA, using cDNA probes for catalase, copper/zinc-containing superoxide dismutase, and glutathione peroxidase. Catalase gene expression decreases during development of renal failure; this decrease is accompanied by decreased catalase activity during the glomerulosclerosis phase of the remnant-kidney model. Copper/zinc superoxide dismutase and glutathione peroxidase gene expression remain at a normal level during progression of the model, whereas their activities show a temporary decrease in the early remnant kidney. In the remnant-kidney model, catalase seems to be more vulnerable to reactive oxygen intermediates than superoxide dismutase and glutathione peroxidase. Our results show that antioxidant enzyme activity and gene expression do not change in the same direction at all times during disease development and that all antioxidant enzymes do not respond in the same way.


Asunto(s)
Catalasa/genética , Expresión Génica , Glutatión Peroxidasa/genética , Fallo Renal Crónico/enzimología , Nefrectomía , Superóxido Dismutasa/genética , Actinas/análisis , Animales , Antioxidantes/metabolismo , Riñón/patología , Riñón/fisiopatología , Corteza Renal/enzimología , Fallo Renal Crónico/patología , Fallo Renal Crónico/fisiopatología , Masculino , Músculo Liso/química , ARN Mensajero/análisis , Ratas , Ratas Wistar
5.
Nephron ; 80(2): 214-9, 1998 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9736823

RESUMEN

In rats with five-sixths nephrectomy (remnant kidney), blood pressure, glomerulosclerosis, and proteinuria are significantly reduced by administration of the angiotensin-converting enzyme inhibitor enalapril, during 16 weeks after reduction of the nephron number. The activity of catalase in remnant-kidney cortex homogenate is not influenced by enalapril treatment; the activities of superoxide dismutase and glutathione peroxidase are significantly increased. Elevated lipid peroxidation in cortex homogenates, evaluated by malondialdehyde and 4-hydroxynonenal concentrations, is not changed by treatment. Supplementation of dietary vitamin E to enalapril treatment does not alter antioxidant enzyme activities when compared to enalapril monotherapy. These results show that enalapril improves the balance between reactive oxygen intermediates and antioxidant enzymes in the remnant-kidney cortex of the rat. This finding may in part explain the protective effect of angiotensin-converting enzyme inhibitors on the progression of glomerulosclerosis.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Antioxidantes/metabolismo , Enalapril/uso terapéutico , Glutatión Peroxidasa/metabolismo , Corteza Renal/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Animales , Glomeruloesclerosis Focal y Segmentaria/tratamiento farmacológico , Glomeruloesclerosis Focal y Segmentaria/metabolismo , Corteza Renal/metabolismo , Pruebas de Función Renal , Peroxidación de Lípido/efectos de los fármacos , Masculino , Nefrectomía , Ratas , Ratas Wistar
6.
Prostaglandins Other Lipid Mediat ; 55(4): 237-44, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9644114

RESUMEN

We investigated peroxisomal alterations in mice treated with different doses of Lorenzo's Oil (a therapy for X-linked adrenoleukodystrophy patients) for up to 100 days. Hepatic erucic acid levels were already significantly increased 2.2-fold and 2.6-fold in mice treated with 10% and 20% Lorenzo's Oil for 21 days, respectively. No lipidosis was found in liver, myocardium and kidney of any of the treated mice. While hepatic catalase, lauroyl-CoA oxidase and glycolate oxidase, and renal catalase activities were not induced by either diet, myocardial catalase activity was increased in most groups. This suggests that the mechanism of the effect of Lorenzo's Oil in X-linked adrenoleukodystrophy patients may not be a direct effect on the peroxisomes.


Asunto(s)
Grasas Insaturadas en la Dieta/farmacología , Ácidos Erucicos/farmacología , Microcuerpos/efectos de los fármacos , Trioleína/farmacología , Acil-CoA Deshidrogenasa , Adrenoleucodistrofia/tratamiento farmacológico , Oxidorreductasas de Alcohol/análisis , Animales , Catalasa/análisis , Combinación de Medicamentos , Ácidos Erucicos/análisis , Ácido Graso Desaturasas/análisis , Ácidos Grasos/metabolismo , Corazón/efectos de los fármacos , Riñón/efectos de los fármacos , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratones , Microcuerpos/metabolismo , Miocardio/metabolismo , Ácido Oléico/análisis , Especificidad de Órganos
7.
Lipids ; 33(5): 539-43, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9625603

RESUMEN

We report on hepatic effects obtained in vivo by treating mice with different doses of fenoprofen, an arylpropionic acid previously shown to inhibit in vitro peroxisomal very long chain fatty acid oxidation. A strong and dose-related induction of peroxisomal palmitoyl-CoA oxidase, and of carnitine acyltransferase and acyl-CoA hydrolase activities was recorded in liver homogenates of mice fed diets supplemented with different contents [0.01, 0.05, 0.1, or 1% (w/w)] of fenoprofen for 6 d. Peroxisomal glycolate oxidase and mitochondrial butyryl-CoA, octanoyl-CoA, and palmitoyl-CoA dehydrogenases were unaffected or increased. Hepatic catalase activity was significantly increased in mice fed the diet with 0.05 and 0.1% fenoprofen but, surprisingly, was not stimulated in mice fed the 1% fenoprofen-containing diet. A time-related but unequal induction of acyl-CoA oxidases and catalase was observed with the 0.1% fenoprofen diet: at 21 d of treatment, the induction of lignoceroyl-CoA and palmitoyl-CoA oxidase activities were five-fold stronger than that of catalase activity. In mice treated with 1% fenoprofen for up to 6 d, only acyl-CoA oxidase activities were found to be significantly increased. Morphometric analysis of the liver peroxisomes in mice treated with 0.1% fenoprofen evidenced an increase in size, volume density, and surface density along with a reduced ratio between perimeter and area of the peroxisomal profiles. No morphological marker for very long chain fatty acid deposition could be detected in livers from fenoprofen-treated animals. Our findings clearly demonstrate that fenoprofen acts as a peroxisome proliferator in the liver of mice and do not support the occurrence of in vivo reduction of very long chain fatty acid oxidation in liver from treated animals.


Asunto(s)
Inhibidores de la Ciclooxigenasa/farmacología , Fenoprofeno/farmacología , Hígado/efectos de los fármacos , Microcuerpos/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Carnitina Aciltransferasas/metabolismo , Hígado/enzimología , Hígado/ultraestructura , Masculino , Ratones , Ratones Endogámicos , Microcuerpos/enzimología , Microcuerpos/ultraestructura , Tamaño de los Órganos/efectos de los fármacos , Oxidorreductasas/metabolismo , Palmitoil-CoA Hidrolasa/metabolismo , Factores de Tiempo
8.
APMIS ; 106(2): 339-44, 1998 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9531968

RESUMEN

Part of the bile acid synthesis takes place in peroxisomes. An altered enterohepatic circulation of bile acids might influence peroxisomal beta-oxidation enzymes and peroxisomal morphology. We performed a morphological and morphometric investigation of peroxisomes in liver biopsy samples of eight patients with cholestasis of different origin: graft versus host reaction (n = 1), obstruction of the bile flow (n = 3), and drug-induced cholestatic hepatitis (n = 4). Peroxisomes were identified using catalase cytochemistry. They were regularly shaped and showed individual differences in electron density. A perinuclear distribution was observed in a variable number of hepatocytes in each sample. Morphometric analysis of peroxisomes revealed an increase in numerical density and surface density in all, and a decreased mean diameter in four liver samples. Based on previously obtained data in experimental animals, we hypothesize that the observed alterations in peroxisomal morphology indicate an enhanced metabolic activity of the enzymes in the peroxisomal matrix. Among them are enzymes involved in bile acid synthesis.


Asunto(s)
Colestasis/patología , Hígado/patología , Microcuerpos/patología , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/análisis , Catalasa/análisis , Colestasis/enzimología , Colestasis/metabolismo , Colestasis Extrahepática/enzimología , Colestasis Extrahepática/patología , Colestasis Intrahepática/enzimología , Colestasis Intrahepática/patología , Femenino , Humanos , Hígado/enzimología , Masculino , Microcuerpos/enzimología , Persona de Mediana Edad
9.
Clin Neuropathol ; 17(1): 6-11, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9496533

RESUMEN

We studied the correlation between the in vitro contracture test (IVCT) performed in malignant hyperthermia (MH) and the muscle fiber type composition in 29 human vastus lateralis (VL) biopsy samples (from 12 women and 17 men) using a semiautomated image analyzer. Relative number, lesser diameter, global area, and spatial distribution of the muscle fibers were measured. In these and in 26 additional VL muscle biopsy samples of patients with other myopathies, we compared our morphometric data with the observations made by the pathologist. Among the MH group, type 1 fibers were larger in both malignant hyperthermia susceptible (MHS) men and women reaching statistical significance only in the latter. The relative number and global area were unchanged. In MHS patients relative number and global area of type 2A fibers were smaller. No changes in the parameters of type 2B fibers were found. In a minority of sections (14%) clustering was observed. Sex-related alterations in type 2 fiber characteristics were found between MHS patients. However, our findings do not clearly point towards a syndrome-induced alteration of size, number, global area, or distribution of type 1, 2A, and 2B muscle fibers in VL of MH patients. By morphometric analysis, we found several additional biopsy samples that met the interpretation of "abnormal" size and number of muscle fibers in human malignant hyperthermia than were reported by the pathologist.


Asunto(s)
Hipertermia Maligna/patología , Fibras Musculares Esqueléticas/patología , Adolescente , Adulto , Anciano , Automatización , Biopsia , Susceptibilidad a Enfermedades , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador , Masculino , Persona de Mediana Edad
10.
APMIS ; 105(8): 631-6, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9298102

RESUMEN

An increased H2O2 production and a decreased activity of several peroxisomal oxidases have previously been reported in kidneys of rats with five-sixth nephrectomy, a model for chronic renal failure. We investigated the morphological and morphometric characteristics of peroxisomes, the organelles in which an important part of cellular H2O2 metabolism is localized, in remnant kidneys 16 weeks after operation. The vast majority of renal peroxisomes were found in the epithelial cells of proximal tubules. The organelles were distributed throughout the cells. We observed a significant increase in size, perimeter and volume density of the peroxisomes as compared to normal kidneys. Elongated peroxisomes were less frequent. An inverse linear correlation between mean size and number of peroxisomes was found. In cortex homogenates, the activity of catalase the peroxisomal H2O2-scavenging enzyme, was significantly decreased and was inversely proportional to the mean peroxisomal diameter. The observed morphological adaptations are believed to create an unfavorable situation for the enzymatic activities in remnant kidney peroxisomes.


Asunto(s)
Fallo Renal Crónico/patología , Túbulos Renales Proximales/patología , Microcuerpos/patología , Adaptación Biológica , Animales , Catalasa/aislamiento & purificación , Histocitoquímica , Túbulos Renales Proximales/enzimología , Masculino , Microcuerpos/enzimología , Nefrectomía , Ratas , Ratas Wistar
11.
Nephron ; 76(1): 77-81, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9171304

RESUMEN

In rats with five-sixth nephrectomy (remnant kidney), glomerulosclerosis was significantly reduced by dietary administration of vitamin E (alpha-tocopherol) during 11 and 16 weeks after reduction of nephron number. The activity of catalase and the production of H2O2 in remnant kidney cortex homogenate were not influenced by the vitamin E diet; however, the activities of glutathione peroxidase and superoxide dismutase were significantly increased (up to 140 and 180%, respectively, after 16 weeks). Lipid peroxidation, evaluated by malonaldehyde and 4-hydroxynonenal concentrations, was decreased in cortex homogenates and in urine. Though the extent of the effect of vitamin E on antioxidant enzyme levels and lipid peroxidation is small, the important reduction of glomerulosclerosis is in favor of dietary supplementation with vitamin E.


Asunto(s)
Antioxidantes/metabolismo , Glomeruloesclerosis Focal y Segmentaria/tratamiento farmacológico , Glomeruloesclerosis Focal y Segmentaria/enzimología , Peroxidación de Lípido/efectos de los fármacos , Vitamina E/farmacología , Animales , Catalasa/metabolismo , Glomeruloesclerosis Focal y Segmentaria/cirugía , Peróxido de Hidrógeno/metabolismo , Riñón/enzimología , Riñón/cirugía , Pruebas de Función Renal , Masculino , Nefrectomía , Ratas , Ratas Wistar
12.
Nephron ; 77(3): 319-24, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9375827

RESUMEN

Nephron loss leads to increased production of reactive oxygen intermediates. We measured the effect of carvedilol, a beta-blocking drug with radical scavenging properties, on renal function, glomerulosclerosis, antioxidant enzyme status and in vivo hydrogen peroxide (H2O2) production in rats with chronic renal failure caused by 5/6 nephrectomy (remnant kidney) and compared results to data obtained with propranolol, a beta-blocking drug without scavenging characteristics. Carvedilol and propranolol were administered during 11 weeks following reduction of nephron number. Kidneys were examined using enzymatic and histological techniques. Both carvedilol and propranolol decreased systolic blood pressure. Compared to propranolol, carvedilol offered some additional beneficial effects on renal function, particularly with regard to glomerulosclerosis. Lipid peroxidation, evaluated by malonaldehyde and 4-hydroxynonenal concentration in cortex homogenates, was decreased in carvedilol-treated rats only. Superior beneficial effect of carvedilol treatment is not linked to a significant up-regulation of the activities of the remnant kidney antioxidant enzymes (catalase, glutathione peroxidase and superoxide dismutase) or to a decreased in vivo H2O2 production.


Asunto(s)
Antioxidantes/metabolismo , Carbazoles/uso terapéutico , Depuradores de Radicales Libres/uso terapéutico , Glomeruloesclerosis Focal y Segmentaria/tratamiento farmacológico , Corteza Renal/enzimología , Propanolaminas/uso terapéutico , Propranolol/uso terapéutico , Antagonistas Adrenérgicos beta/farmacología , Antagonistas Adrenérgicos beta/uso terapéutico , Aldehídos/metabolismo , Animales , Presión Sanguínea/efectos de los fármacos , Carbazoles/farmacología , Carvedilol , Depuradores de Radicales Libres/metabolismo , Glomeruloesclerosis Focal y Segmentaria/metabolismo , Peróxido de Hidrógeno/metabolismo , Fallo Renal Crónico/tratamiento farmacológico , Fallo Renal Crónico/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Nefrectomía , Propanolaminas/farmacología , Propranolol/farmacología , Ratas , Ratas Wistar
13.
Lipids ; 31(11): 1157-61, 1996 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8934448

RESUMEN

NMRI mice were fed diets supplemented with 0.05, 0.2, or 2% (w/w) docosahexaenoic acid (DHA), a polyunsaturated fatty acid present in fish oil, for 3 d, 3 wk, or 3 mon. The doses of DHA were chosen to supply the mice with concentrations of DHA which approximate those that have been reported to be beneficial to patients with peroxisomal disease. Diets containing 0.05 or 0.2% DHA did not change hepatic, myocardial, and renal catalase (EC 1.11.1.6) activity except for a slight but significant increase (to 120%) in myocardial catalase activity in mice treated with the 0.05% DHA diet for 3 mon. A diet with 2% DHA induced myocardial catalase activity to 150% after both 3 d and 3 wk of administration. In the liver of mice fed this diet for 3 wk, hepatic catalase activity was increased to 140% while no induction of palmitoyl-CoA oxidase (EC 1.3.99.3), urate oxidase (EC 1.7.3.3), and L-alpha-hydroxyisovalerate oxidase (EC 1.1.3.a) was observed. With the light microscope, no changes in peroxisomal morphology were visually evaluated in catalase stained sections of liver, myocardium, and kidney of mice fed either diet. Our results show that in healthy mice a low dietary DHA dose (< 0.2%; this corresponds to a dose prescribed to peroxisomal patients) has no effect on several hepatic peroxisomal H2O2-producing enzymes, including the rate-limiting enzyme of the peroxisomal fatty acid beta-oxidation. This may indicate that such a DHA dose will not add a strong load on the often disturbed fatty acid metabolism in the liver of patients with peroxisomal disorders.


Asunto(s)
Grasas Insaturadas en la Dieta/administración & dosificación , Ácidos Docosahexaenoicos/administración & dosificación , Microcuerpos/efectos de los fármacos , Acil-CoA Oxidasa , Animales , Catalasa/biosíntesis , Inducción Enzimática/efectos de los fármacos , Corazón/efectos de los fármacos , Peróxido de Hidrógeno/metabolismo , Riñón/efectos de los fármacos , Riñón/enzimología , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , Ratones , Microcuerpos/metabolismo , Microcuerpos/ultraestructura , Miocardio/enzimología , Oxidorreductasas/metabolismo , Trastorno Peroxisomal/dietoterapia , Trastorno Peroxisomal/enzimología , Factores de Tiempo , Urato Oxidasa/metabolismo
14.
Histopathology ; 29(2): 171-3, 1996 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8872152

RESUMEN

We report a patient with fibrinogen storage disease in which there was proliferation of normal-sized peroxisomes in the hepatocytes. this phenomenon has previously been described in several acquired liver diseases. We believe that this is an adaptation response due to decreased microsomal isoenzyme activity as a result of the excess accumulation of fibrinogen in the endoplasmic reticulum.


Asunto(s)
Fibrinógeno/metabolismo , Hepatopatías/patología , Hígado/patología , Errores Innatos del Metabolismo/patología , Microcuerpos/patología , Niño , Femenino , Humanos , Hepatopatías/diagnóstico , Errores Innatos del Metabolismo/diagnóstico
15.
Alcohol Clin Exp Res ; 20(5): 908-13, 1996 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8865967

RESUMEN

Hepatocellular peroxisomes harbor one of the metabolic pathways for ethanol metabolism (i.e., catalase in the presence of H2O2-generating enzymes). We studied the morphometric characteristics of these organelles in 26 biopsy samples of patients with different alcohol-induced lesions (12 with steatosis, 5 with hepatitis, and 9 with cirrhosis) and compared the findings with those obtained in seven control livers. All 33 human liver biopsy samples were stained for catalase activity to facilitate peroxisomal identification. Morphometric analysis of the peroxisomes was performed on calibrated electron micrographs. The numerical density of the peroxisomes was significantly increased to 183%, whereas the mean peroxisomal diameter (dcircle) revealed a significant decrease to 89%. This resulted in a normal volume density of the peroxisomal compartment, whereas the surface density was significantly induced. Peroxisomal shape was not different between alcoholic and control livers. When alcoholic livers were divided into three subgroups according to histopathological findings, similar morphometric results were obtained when compared with control livers, although significantly was sometimes lost. No differences in peroxisomal characteristics were found among alcoholic subgroups. The mean peroxisomal diameter per human liver (alcoholic and control) was inversely correlated to the numerical density. It is concluded that the peroxisomal adaptation in human alcoholic liver is such as to create an efficient environment for a presumably increased peroxisomal metabolism.


Asunto(s)
Hepatopatías Alcohólicas/patología , Hígado/patología , Microcuerpos/patología , Adulto , Biopsia , Etanol/farmacocinética , Femenino , Humanos , Masculino , Persona de Mediana Edad , Valores de Referencia
16.
Hepatology ; 22(3): 744-52, 1995 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-7657278

RESUMEN

We investigated the hepatocellular peroxisomes in 27 patients with steatosis of the liver by means of catalase cytochemistry, light and electron microscopic study, and morphometry. Seven normal human livers were used as controls. In our patients, fatty liver was mainly associated with alcohol abuse or obesity. Indications for a slight decrease in catalase activity and for a proliferation were found in visual evaluation of the peroxisomes. Morphometric analysis showed a significant decrease in mean peroxisomal diameter (to 87%) and a simultaneous significant elevation to numerical density of the peroxisomes (to 188%); this resulted in a normal volume density and a significant increase to (133%) in surface density. However, individual differences were found. No differences in peroxisomal characteristics were found between fatty livers of different causes. A significant inverse linear correlation between mean peroxisomal diameter and numerical density was found in patients with fatty livers. Because a similar correlation was also found when control data were added to the fatty liver data, we hypothesize that the peroxisomal compartment in human fatty livers is adapted in such a way to permit the same metabolic efficiency as in control livers.


Asunto(s)
Hígado Graso/patología , Microcuerpos/ultraestructura , Adulto , Catalasa/metabolismo , Hígado Graso/enzimología , Hígado Graso/etiología , Femenino , Histocitoquímica , Humanos , Hígado/enzimología , Hígado/ultraestructura , Hepatopatías Alcohólicas/patología , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Obesidad/complicaciones
17.
Lipids ; 30(8): 701-5, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7475984

RESUMEN

The influence of low dietary doses (0.1 and 0.8% w/w) of a commercial fish oil preparation on peroxisomes in normal mice was studied and compared to the known strong inductive effects of high (10%) fish oil diets. Low fish oil doses were chosen to supply the mice with a concentration of docosahexaenoic acid, which was beneficial to patients with a peroxisomal disease. Peroxisomes were evaluated by cytochemical, morphometric, and enzymological techniques. The 0.1% fish oil diet had no effect on peroxisomes in liver, heart, and kidney even after prolonged treatment. The 0.8% diet did not change the peroxisomal number nor the catalase (EC 1.11.1.6) activity in the liver. Hepatic peroxisomal beta-oxidation, however, was increased by 50% after 14 d. This was accompanied by reduced peroxisomal size. The 0.8% diet also caused a small increase (+25%) in myocardial catalase activity. No effect was observed in kidneys. Our results indicate that in mice a low (< 0.8%) dietary fish oil dose has no or only a slight effect on hepatic peroxisomal beta-oxidation. This may be of particular interest to patients with a peroxisomal fatty acid beta-oxidation defect and who display a severe deficiency of docosahexaenoic acid--diets supplemented with low fish oil doses will improve the docosahexaenoic acid level without adding a strong load to the disturbed fatty acid metabolism.


Asunto(s)
Grasas Insaturadas en la Dieta/administración & dosificación , Aceites de Pescado/administración & dosificación , Microcuerpos/ultraestructura , Animales , Catalasa/metabolismo , Ácidos Docosahexaenoicos/administración & dosificación , Riñón/enzimología , Riñón/ultraestructura , Hígado/enzimología , Hígado/ultraestructura , Masculino , Ratones , Microcuerpos/metabolismo , Miocardio/enzimología , Miocardio/ultraestructura , Oxidación-Reducción
18.
Ren Physiol Biochem ; 17(5): 240-5, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7527573

RESUMEN

In the rat remnant kidney hydrogen peroxide (H2O2) production is increased when compared to the normal kidney. The activities of the peroxisomal H2O2-producing oxidases, D-amino acid oxidase and acyl-coenzyme A oxidase, and of the extraperoxisomal superoxide dismutase are decreased in renal homogenate. The peroxisomal L-alpha-hydroxyacid oxidase and L-lactate oxidase as well as the peroxisomal H2O2 scavenger catalase preserve their activity. The activity of the cytosolic scavenging system, glutathione peroxidase, is decreased by 40%. A starvation period of 48 h does not produce a measurable increase in H2O2 production in the normal nor in the remnant kidney. On visual inspection, peroxisomal morphology and distribution in the renal tubules are similar in the normal and remnant kidney tissue.


Asunto(s)
Peróxido de Hidrógeno/metabolismo , Riñón/enzimología , Nefrectomía , Amitrol (Herbicida)/farmacología , Animales , Catalasa/metabolismo , Tasa de Filtración Glomerular , Inmunohistoquímica , Riñón/metabolismo , Riñón/ultraestructura , Masculino , Microcuerpos/ultraestructura , Microscopía Electrónica , Oxidorreductasas/metabolismo , Ratas , Ratas Wistar , Sodio/metabolismo , Inanición
19.
J Lipid Res ; 35(7): 1241-50, 1994 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7964185

RESUMEN

Male NMRI mice were fed a diet with 10% w/w Beromegan for up to three weeks. Beromegan is a commercial fish (salmon) oil preparation rich in eicosapentaenoic acid and docosahexaenoic acid. Peroxisomal beta-oxidation capacity, catalase activity, and ultrastructural morphometry of the hepatic peroxisomes were investigated. In myocardium and kidney, catalase activity, peroxisomal staining after catalase cytochemistry, peroxisomal morphology, and morphometry (in myocardium) were evaluated. In liver, we found a significant increase in peroxisomal beta-oxidation, catalase activity, and peroxisomal number already after 3 days of dietary treatment. These changes were more pronounced after 3 weeks. Peroxisomal size was not changed. Positive correlations were found between peroxisomal enzyme activities and the number but not the size of the peroxisomes, and between catalase activity and beta-oxidation capacity. The mean peroxisomal diameter per animal was inversely proportional to catalase activity measured in homogenate. In myocardium, catalase activity was increased with duration of fish oil feeding. Peroxisomal staining, number, and size were also increased when compared to controls. In kidney, no alterations were observed. Our results indicate a beneficial effect of a diet supplemented with fish oil on the peroxisomal metabolism in liver and myocardium; it differs from the changes induced by xenobiotic peroxisome proliferation.


Asunto(s)
Grasas Insaturadas en la Dieta/farmacología , Riñón/ultraestructura , Hígado/ultraestructura , Microcuerpos/ultraestructura , Miocardio/ultraestructura , Animales , Aceites de Pescado/farmacología , Riñón/enzimología , Hígado/enzimología , Masculino , Ratones , Ratones Endogámicos , Microcuerpos/enzimología , Miocardio/enzimología , Tamaño de los Órganos/fisiología , Distribución Aleatoria , Salmón , Especificidad de la Especie
20.
Biochim Biophys Acta ; 1170(2): 151-6, 1993 Oct 13.
Artículo en Inglés | MEDLINE | ID: mdl-8399339

RESUMEN

The present work extends tissue investigations previously performed in rat gastric mucosa on lipid metabolism alterations caused by n-3 and n-6 fatty acid-enriched diets. Liver and heart tissues are here studied and demonstrated to undergo, upon exposure to high fat diets with various n-3/n-6 fatty acid ratio contents, biochemical and morphological changes which may be enumerated as follows: (1) Rat liver peroxisomal prostaglandin E2, fatty acid but not bile acid beta-oxidation rates are enhanced, especially upon the diet with the higher n-3/n-6 fatty acid ratio. Mitochondrial beta-oxidation rates are little or not affected by the high fat diets. (2) Rat liver carnitine acyltransferases are stimulated by the high fat diets, the more rich the n-3 fatty acid content, the more pronounced the stimulatory effect. (3) Rat heart peroxisomal and mitochondrial beta-oxidation rates were increased in animals receiving the n-3 fatty acid-enriched diet. At a low n-3/n-6 fatty acid ratio content of the diet, these oxidizing rate values were in control range. The carnitine acyltransferase activities were increased in rat heart to different extents, depending on the n-3/n-6 fatty acid ratio content of the diet. (4) Ultrastructural examination and morphometric determinations on hepatocytes from rats receiving the diets with the lowest and the highest n-3/n-6 fatty acid ratio contents disclose that in the latter case the numbers and fractional volumes of peroxisomes and mitochondria are significantly higher than in the former case.


Asunto(s)
Grasas de la Dieta/farmacología , Ácidos Grasos Insaturados/farmacología , Corazón/efectos de los fármacos , Hígado/efectos de los fármacos , Miocardio/metabolismo , Acil-CoA Oxidasa , Animales , Ácidos Grasos Omega-3/farmacología , Ácidos Grasos Omega-6 , Hígado/metabolismo , Hígado/ultraestructura , Masculino , Microcuerpos/metabolismo , Mitocondrias/metabolismo , Miocardio/ultraestructura , Oxidación-Reducción , Oxidorreductasas/metabolismo , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...